End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.13 CNY | +1.45% | -6.81% | -7.59% |
Mar. 27 | Fosun Pharma's 2023 Attributable Profit Declines, Misses Estimates | MT |
Mar. 27 | Shanghai Fosun Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 200 million worth of its shares. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.59% | 7.59B | |
+33.46% | 701B | |
+26.24% | 571B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 319B | |
+0.74% | 210B | |
+2.95% | 210B | |
-6.05% | 201B | |
-3.61% | 157B |
- Stock
- Equities
- Stock Shanghai Fosun Pharmaceutical (Group) Co., Ltd. - Shanghai S.E.
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Fosun Pharma Issues $79 Million of Renminbi Bonds in China